Novavax Inc (NASDAQ:NVAX)
| 17.27 Delayed Data As of Dec 08 |  +0.045 / +0.26%Today’s Change | 15.53 Today|||52-Week Range 236.50 | -87.93% Year-to-Date |
Latest NVAX News | Press Releases
| Novavax (NVAX) Down 7.6% Since Last Earnings Report: Can It Rebound? Dec 08 / Zacks.com - Paid Partner Content | Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why Nov 28 / Zacks.com - Paid Partner Content |
| 3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street Dec 06 / MotleyFool.com - Paid Partner Content | Is Novavax Stock a Buy Now? Nov 26 / MotleyFool.com - Paid Partner Content |
| Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL Nov 30 / Zacks.com - Paid Partner Content | 3 Potentially Explosive Stocks to Buy Before 2023 Nov 26 / MotleyFool.com - Paid Partner Content |
| Do Options Traders Know Something About Novavax (NVAX) Stock We Don't? Nov 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.23 |
| Today’s open | 17.24 |
| Day’s range | 16.40 - 17.81 |
| Volume | 123,984 |
| Average volume (3 months) | 5,167,575 |
| Market cap | $1.2B |
Data as of 3:21pm ET, 12/08/2022
Growth & Valuation
| Earnings growth (last year) | -222.51% |
| Earnings growth (this year) | +69.97% |
| Earnings growth (next 5 years) | +58.18% |
| Revenue growth (last year) | +141.02% |
| P/E ratio | NM |
| Price/Sales | 9.29 |
| Price/Book | -- |
Competitors
| ---- | ||
| ALLOAllogene Therapeutic... | -0.05 | -0.55% |
| TVTXTravere Therapeutics... | -0.33 | -1.65% |
| TWSTTwist Bioscience Cor... | -2.19 | -7.69% |
Data as of 3:21pm ET, 12/08/2022
Financials
| Next reporting date | February 27, 2023 |
| EPS forecast (this quarter) | -$1.10 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$1.7B |
| Net profit margin | -152.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
